| Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. | |
| | |
MedLine Citation:
|
PMID: 19910448 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC. |
| | |
Authors:
|
R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier |
Related Documents
:
|
14736838 - Pet/ct in oncology: integration into clinical management of lymphoma, melanoma, and gas... 18550578 - Combined pet and low-dose, noncontrast ct scanning obviates the need for additional dia... 9605668 - Effectiveness of positron emission tomography for the detection of melanoma metastases. 20381368 - Intraoperative control of resection margins in advanced head and neck cancer using a 3d... 22047398 - Development of a human-tissue-like phantom for 3.0-t mri. 12559508 - Remyelination in multiple sclerosis. |
Publication Detail:
|
Type: Journal Article Date: 2009-11-12 |
Journal Detail:
|
Title: AJNR. American journal of neuroradiology Volume: 31 ISSN: 1936-959X ISO Abbreviation: AJNR Am J Neuroradiol Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-13 Completed Date: 2010-07-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8003708 Medline TA: AJNR Am J Neuroradiol Country: United States |
Other Details:
|
Languages: eng Pagination: 598-604 Citation Subset: IM |
Affiliation:
|
Department of Radiology, Boston Medical Center and Boston University, Massachusetts 02118, USA. rathan.subramaniam@bmc.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biopsy, Fine-Needle Carcinoma, Squamous Cell / pathology, radionuclide imaging*, secondary, therapy Disease Progression Fluorodeoxyglucose F18 / diagnostic use* Follow-Up Studies Humans Image Processing, Computer-Assisted* Lymphatic Metastasis / pathology, ultrasonography Neoplasm Recurrence, Local / pathology, therapy, ultrasonography Neoplasm Staging Neoplasm, Residual / pathology, therapy, ultrasonography Neoplasms, Multiple Primary / pathology, therapy, ultrasonography Neoplasms, Unknown Primary / ultrasonography Otorhinolaryngologic Neoplasms / pathology, radionuclide imaging*, secondary, therapy Positron-Emission Tomography* Sensitivity and Specificity Tomography, X-Ray Computed* Tumor Burden |
| Chemical | |
Reg. No./Substance:
|
63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of a Percutaneous Diskectomy Device to Facilitate the Diagnosis of Infectious Spondylitis.
Next Document: Mass Effect in the Thoracic Spine from Remnant Bone Wax: An MR Imaging Pitfall.